We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App





AI Models Can Predict Individual Risk of Hospitalization for COVID Using HIE Data

By HospiMedica International staff writers
Posted on 27 Jan 2022
Print article
Illustration
Illustration

A study has demonstrated how clinical data from healthcare systems can be used to better inform public health decision-making.

In a new study, researchers at Regenstrief Institute (Indianapolis, IN, USA) and Indiana University (Bloomington, IN, USA) demonstrated that machine learning models trained using clinical data from a statewide health information exchange can predict, on a patient level, the likelihood of hospitalization of individuals with the virus. The researchers used clinical data from 96,026 individuals from all 957 zip codes in Indiana to train decision models that predicted healthcare resource utilization.

“It has been quite challenging to bring the bread-and-butter data generated by healthcare systems together with public health decision-making - entities which have long been separate and distinct,” said study senior author Shaun Grannis, M.D., M.S., Regenstrief Institute vice president for data and analytics and professor of family medicine at Indiana University School of Medicine. “Our work shows how you can build and employ AI (artificial intelligence) models to securely utilize the clinical information in a health information exchange to support public health needs such as predicting hospital utilization within one week and within six weeks of onset of COVID infection.

“When new circumstances requiring rapid response arise, such as emergence of omicron or other new variants, once there are sufficient cases to train models, one can confidently access and plug clinical data into these readily available models to make accurate public health predictions and provide valuable insights into patient-level need for healthcare resource utilization,” said Dr. Grannis.

“Since the onset of COVID-19, researchers, healthcare systems, public health departments and others have leveraged existing data repositories and health information infrastructure for rapid analytics,” said study first author Suranga Kasturi, PhD, a Regenstrief Institute research scientist and an assistant professor of pediatrics at IU School of Medicine. “Machine learning has been invaluable in these efforts.”

“But any model is only as good as the data that goes into it,” he added. “The broad, robust data from the Indiana Network for Patient Care is representative of the US population. What we have done could be characterized as a precursor of how AI tools can be deployed across the entire country with the important caveat that whatever models are used should be evaluated for fairness across all subpopulations.”

Related Links:
Regenstrief Institute 
Indiana University 

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Tablet Cart
Tryten P1
New
Bioengineered Collagen Implant
Tapestry Biointegrative Implant

Print article

Channels

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.